NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics

/PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP) filed a lawsuit on Monday against Relief Therapeutics (SIX: RLF, OTCQB: RLFTF, RLFTY), its former...

Related Keywords

Texas ,United States ,Miami ,Florida ,Radnor ,Powys ,United Kingdom ,Israel ,Washington ,Daniele Troy ,Francis Collins ,Whit Clay ,Sherry Glied ,Raghuram Selvaraju ,Jacobo Elgozy ,Hc Wainwright Bioconnect ,Chaim Hurvitz ,Jack Weinstein ,Jonathan Javitt ,Nrx Pharmaceuticals ,Phd Us Army ,Israel Ministry Of Defense ,Novartis ,Pfizer ,Prnewswire Nrx Pharmaceuticals Nasdaq ,Source Nrx Pharmaceuticals ,York State Supreme Court ,European Union ,Allergan ,Us Department Of Health ,Israel Institute For Biological Research ,National Institutes Of Health ,Biomedical Advanced Research ,Human Services ,Drug Administration ,United States National Security Advisor ,Development Authority ,Nrx Pharmaceuticals Inc ,Exchange Commission ,National Institutes For Allergy ,Teva International Group ,Us Department Of Defense ,Us National Institutes Of Health ,Sloane Company ,Relief Therapeutics ,New York State Supreme ,National Institutes ,Prof Jonathan Javitt ,Federal Right ,Try Act ,Bioconnect Virtual Healthcare Conference ,United States Federal ,Good Manufacturing Practices ,Infectious Diseases ,Chief Medical Officer ,New York State Supreme Court ,Israel Institute ,Biological Research ,Israel Ministry ,Fast Track ,Medical Countermeasures ,Breakthrough Therapy Designation ,Special Protocol Agreement ,Biomarker Letter ,Chief Counsel ,United States National Security ,Vasoactive Intestinal Polypeptide ,Sami Said ,Securities Litigation Reform Act ,